Antigenic fractions of Leishmania (Viannia) braziliensis: The immune response characterization of patients at the initial phase of disease

Parasite Immunology

Volumn 34, Issue 4, 2012, Pages 236-239

  Brelaz, M C A ^a   De Oliveira, A P ^a   De Almeida, A F ^a   De Assis Souza, M ^a   Medeiros, A C R ^b   De Brito, M E F ^a   Pereira, V R A ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

American cutaneous leishmaniasis; Cytokines; Flow cytometry; Immune response

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; AMERICAN CUTANEOUS LEISHMANIASIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FRACTIONATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; INFECTION SENSITIVITY; LEISHMANIA BRAZILIENSIS; MALE; NONHUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, PROTOZOAN; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; TH2 CELLS; TIME FACTORS; YOUNG ADULT;

LEISHMANIA BRAZILIENSIS;

EID: 84857975173     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2012.01351.x     Document Type: Article

References (16)

1. Telino E, De Luca PM, Matos DCS, et al. In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes. Clin Exp Immunol 2005; 143: 338-344.
2. Brito MEF, Andrade MS, Mendonça MG, et al. Species diversity of Leishmania (Viannia) parasites circulating in an endemic area for cutaneous leishmaniasis located in the Atlantic rainforest region of northeastern Brazil. Trop Med Int Health 2009; 14: 1278-1286.
3. Toledo VP, Mayrink W, Gollob KJ, et al. Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment. Mem Inst Oswaldo Cruz 2001; 96: 89-98.
4. Leopoldo PTG, Machado PRL, Almeida RP, et al. Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production. BMC Infect Dis 2006; 6: 75.
5. Reis LC, Brito MEF, Souza MA, et al. Cellular immune response profile in patients with American tegumentary leishmaniasis prior and post chemotherapy treatment. J Clin Lab Anal 2009; 23: 63-69.
6. Salhi A, Rodrigues VJ, Santoro F, et al. Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis. J Immunol 2008; 180: 6139-6148.
7. Castellano LR, Filho DC, Argiro L, et al. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production. Hum Immunol 2009; 70: 383-390.
8. Da-Cruz AM, Bittar R, Mattos M, et al. T-Cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy. Clin Diagn Lab Immunol 2002; 9: 251-256.
9. Coutinho SG, Oliveira MP, Da-Cruz AM, et al. T-Cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote Antigens: immunologic patterns associated with cure. Exp Parasitol 1996; 84: 144-155.
10. Brito MEF, Mendonça MG, Gomes YM, Jardim ML & Abath FGC. Dynamics of the antibody response in patients with therapeutic or spontaneous cure of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 2001; 95: 203-206.
11. Baran J, Kowalczyk D, Ozóg M & Zembala M. Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: comparative analysis of phorbol myristate acetate-ionomycin and phytohemagglutinin stimulation. Clin Diagn Lab Immunol 2001; 8: 303-313.
12. Godoy-Ramirez K, Franck K, Mahdavifar S, Andersson L & Gaines H. Optimum culture conditions for specific and nonspecific activation of whole blood and PBMC for intracellular cytokine assessment by flow cytometry. J Immunol Methods 2004; 292: 1-15.
13. Baratta-Masini A, Teixeira-Carvalho A, Malaquias LCC, Mayrink W, Martins-Filho AO & Corrêa-Oliveira R. Mixed cytokine profile during active cutaneous leishmaniasis and in natural resistance. Front Biosci 2007; 12: 839-849.
14. Bottrel RLA, Dutra WO, Martins FA, et al. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and Soluble leishmania antigen in human cutaneous leishmaniasis. Infect Immun 2001; 69: 3232-3239.
15. Kemp K, Theander TG, Hviid L, Garfar A, Kharazmi A & Kemp M. Interferon-γ and tumour necrosis factor-α -producing cells in humans who are immune to cutaneous leishmaniasis. Scand J Immunol 1999; 49: 655-659.
16. Bourreau E, Ronet C, Darcissa CE, et al. Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis. Infect Immun 2009; 77: 1465-1474.